Total number of patients |
37 |
Median (range) age, years |
56 (34–84) |
Gender, n (%) |
|
Male |
12 (32.4) |
Female |
25 (67.6) |
Race/Ethnicity, n (%) |
|
White non-Hispanic |
8 (21.6) |
Hispanic grouped |
29 (78.4) |
Median (range) body mass index |
30.4 (20.1–43) |
Charlson comorbidity score, n (%) |
|
0 |
16 (43.2) |
1 |
10 (27.0) |
2 |
4 (10.8) |
3 |
6 (16.2) |
5 |
1 (2.7) |
Median (range) ischaemia time, min |
|
Ischaemia (all) |
32 (15–61) |
Warm ischaemia (n = 25) |
31 (15–53) |
Cold ischaemia (n = 12) |
48 (30–61) |
Median (range) estimated blood loss, mL |
200 (50–1000) |
Median (range) total operative time, min |
155 (78–269) |
Pathology lesion type, n (%) |
|
Clear-cell |
28 (75.7) |
Papillary |
1 (2.7) |
Oncocytoma |
2 (5.4) |
Angiomyolipoma |
1 (2.7) |
Benign simple cyst |
3 (8.1) |
Benign parenchyma |
1 (2.7) |
Sarcomatoid changes |
1 (2.7) |
Median (range) tumour/lesion size, cm |
4 (2–7.2) |
Margin status: negative, n (%) |
37 (100) |